Vasudev Bailey

Vasudev (“Vas”) Bailey, Ph.D., is a Senior Partner of ARTIS Ventures. He focuses on investing in novel and breakthrough health and life sciences companies. He currently sits on 10 boards, including Eko, Unnatural Products, Inc., Aether, IDbyDNA, Association for Women in Sciences (AWIS), Johns Hopkins Biomedical Engineering, and The Trevor Project. He has led ARTIS investments in Freenome, Replay Therapeutics, and Climax Foods. He is the founder of the ARTIS Ventures Healthcare Pioneers, which brings together some of the world’s brightest minds to accelerate and incubate life-changing ideas in healthcare.

Vasudev received his PhD in Biomedical Engineering from the Johns Hopkins School of Medicine where he was recognized as both a Siebel and a Medtronic Scholar and member of Sigma Xi. He graduated magna cum laude and phi beta kappa from UC Irvine with a degree in biomedical engineering and was both a Regents Scholar, Hodson Foundation fellow, Whitaker Foundation Fellow, and Henri Samueli Endowed Scholar.

Vasudev is a seasoned speaker, having presented on the topic of biotech, healthcare, and entrepreneurism at events including DTx West, Health 2.0, GIANT Health, Johns Hopkins Research Symposium on Engineering in Healthcare, AWIS Summit, and East/West CEO, and has been a distinguished guest lecturer at UC Irvine and Johns Hopkins. He has been quoted as an expert on biotech and healthcare in CNBC, Venture Capital Journal, HIT Consultant, Startupedia, International Business Times, and more.

Vasudev Bailey is the Senior Partner at Artis Ventures (AV), based in United States, North America. With a background in Financial Services, Vasudev Bailey has a rich history of leadership and innovation. Vasudev Bailey studied PhD Biomedical Engineering @ Johns Hopkins University School of Medicine. Explore their detailed professional journey, key connections, and contributions to the industry on our platform.